Skip to main navigation Skip to search Skip to main content

Fisetin-loaded nanoemulsion ameliorates lung cancer pathogenesis via downregulating cathepsin-B, galectin-3 and enolase in an in vitro setting

  • Ayeh Bani Saeid
  • , Keshav Raj Paudel
  • , Gabriele De Rubis
  • , Samir Mehndiratta
  • , Sofia Kokkinis
  • , Sukriti Vishwas
  • , Stewart Yeung
  • , Gaurav Gupta
  • , Sachin Kumar Singh
  • , Kamal Dua
  • University of Technology Sydney
  • Centenary Institute
  • Lovely Professional University
  • Chitkara University, Punjab
  • Ajman University

Research output: Contribution to journal › Article › peer-review

6 Citations (Scopus)
1 Downloads (Pure)

Abstract

Lung cancer (LC) remains one of the leading causes of cancer-related deaths worldwide, with a high incidence and mortality rate (Barta et al., 2019). According to the World Health Organization (WHO), in 2020 alone, around 2 million LC diagnoses and 1.8 million deaths worldwide were recorded, showing its great burden on public health (WHO, 2023).
Original languageEnglish
Pages (from-to)1238-1244
Number of pages7
JournalEXCLI Journal
Volume23
DOIs
Publication statusPublished - 3 Jan 2024
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Fisetin-loaded nanoemulsion ameliorates lung cancer pathogenesis via downregulating cathepsin-B, galectin-3 and enolase in an in vitro setting'. Together they form a unique fingerprint.

Cite this